← Open Payments lookup

MICHAEL CLOY: Open Payments

NPI 1447230263 · BROWNWOOD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$662 in 32 payments from 15 companies in 2025. Trend: 2023 $441 · 2024 $313 · 2025 $662

Food & beverage: $632Long term medical supply or device loan: $30
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.5$195
ABBVIE INC.4$85
Novo Nordisk Inc5$76
Exact Sciences Corporation3$48
PFIZER INC.2$37
Bayer Healthcare Pharmaceuticals Inc.2$34
Abbott Laboratories1$30
Phathom Pharmaceuticals, Inc.3$27
E.R. Squibb & Sons, L.L.C.1$25
Alnylam Pharmaceuticals Inc.1$20

Products named: JARDIANCE, VRAYLAR, Cologuard Collection Kit, Ozempic, ELIQUIS, Kerendia, QULIPTA, Rybelsus.

Industry payments across TX — which companies pay providers there.